ADS · CUSIP 86366E106 · who reports it, how much, and how much it matters to them
38 of the 720 hedge fund managers we track reported shares of Structure Therapeutics Inc. (Nasdaq: GPCR) on Form 13F for 30 June 2026. Between them they reported USD 1.1bn. The largest position belongs to Avoro Capital Advisors, at USD 352m. The manager with the most riding on it is Deep Track Capital, where it is 3.7% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Avoro Capital Advisors1 fund on PPLI.com | USD 352m | 3.2% |
| 2 | Deep Track Capital1 fund on PPLI.com | USD 254m | 3.7% |
| 3 | Orbimed Advisors1 fund on PPLI.com | USD 119m | 2.2% |
| 4 | RTW Investments2 funds on PPLI.com | USD 86m | 0.7% |
| 5 | Baker Bros. Advisors2 funds on PPLI.com | USD 77m | 0.4% |
| 6 | Casdin Capital3 funds on PPLI.com | USD 63m | 3.2% |
| 7 | Rock Springs Capital Management2 funds on PPLI.com | USD 34m | 1.7% |
| 8 | Logos Global Management1 fund on PPLI.com | USD 27m | 1.2% |
| 9 | Marshall Wace LLP84 funds on PPLI.com | USD 14m | 0.0% |
| 10 | Two Sigma Investments35 funds on PPLI.com | USD 11m | 0.0% |
| 11 | Eversept Partners3 funds on PPLI.com | USD 11m | 0.5% |
| 12 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 10m | 0.0% |
| 13 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 8.1m | 0.3% |
| 14 | HighVista Strategies27 funds on PPLI.com | USD 7m | 1.6% |
| 15 | Squarepoint Ops7 funds on PPLI.com | USD 6.7m | 0.0% |
| 16 | D. E. Shaw & Co.15 funds on PPLI.com | USD 6.2m | 0.0% |
| 17 | Voloridge Investment Management6 funds on PPLI.com | USD 6m | 0.0% |
| 18 | PFM Health Sciences3 funds on PPLI.com | USD 4.9m | 0.4% |
| 19 | Platinum Investment Management11 funds on PPLI.com | USD 4.8m | 1.2% |
| 20 | Millennium Management6 funds on PPLI.com | USD 4.8m | 0.0% |
| 21 | Exoduspoint Capital Management7 funds on PPLI.com | USD 4.2m | 0.0% |
| 22 | Boxer Capital Management1 fund on PPLI.com | USD 4m | 0.3% |
| 23 | Cormorant Asset Management1 fund on PPLI.com | USD 4m | 0.2% |
| 24 | Adage Capital Management1 fund on PPLI.com | USD 4m | 0.0% |
| 25 | Brevan Howard Capital Management39 funds on PPLI.com | USD 3.3m | 0.0% |
| 26 | Burkehill Global Management5 funds on PPLI.com | USD 3.2m | 0.1% |
| 27 | Tudor Investment Corporation10 funds on PPLI.com | USD 2.9m | 0.0% |
| 28 | Dafna Capital Management6 funds on PPLI.com | USD 2.5m | 0.5% |
| 29 | Cinctive Capital Management5 funds on PPLI.com | USD 2.2m | 0.1% |
| 30 | Capital Fund Management S.A.12 funds on PPLI.com | USD 2m | 0.0% |
| 31 | Sphera Funds Management1 fund on PPLI.com | USD 1.5m | 0.2% |
| 32 | Verition Fund Management3 funds on PPLI.com | USD 1.5m | 0.0% |
| 33 | Wexford Capital8 funds on PPLI.com | USD 736,000 | 0.1% |
| 34 | Brandywine Managers47 funds on PPLI.com | USD 717,000 | 0.4% |
| 35 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 685,000 | 0.1% |
| 36 | Verdad Advisers6 funds on PPLI.com | USD 608,000 | 0.6% |
| 37 | Entrypoint Capital1 fund on PPLI.com | USD 329,000 | 0.1% |
| 38 | The Quarry1 fund on PPLI.com | USD 13,149 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Deep Track Capital | USD 254m | 3.7% |
| 2 | Avoro Capital Advisors | USD 352m | 3.2% |
| 3 | Casdin Capital | USD 63m | 3.2% |
| 4 | Orbimed Advisors | USD 119m | 2.2% |
| 5 | Rock Springs Capital Management | USD 34m | 1.7% |
| 6 | HighVista Strategies | USD 7m | 1.6% |
| 7 | Platinum Investment Management | USD 4.8m | 1.2% |
| 8 | Logos Global Management | USD 27m | 1.2% |
| 9 | RTW Investments | USD 86m | 0.7% |
| 10 | Verdad Advisers | USD 608,000 | 0.6% |
Structure Therapeutics Inc. trades under the symbol GPCR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 86366E106.
38 of the 720 hedge fund managers PPLI.com tracks reported Structure Therapeutics Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Avoro Capital Advisors (USD 352m), Deep Track Capital (USD 254m), Orbimed Advisors (USD 119m), RTW Investments (USD 86m) and Baker Bros. Advisors (USD 77m).
38 managers in our coverage reported it, and between them they run 425 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Deep Track Capital, where the position was 3.7% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Structure Therapeutics Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.